Constellation Pharmaceuticals Inc
CNST
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
$39.78
17% upside
Current Fair Value
17% upsideUndervalued by 17% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-110,618,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.65 |
| Beta | 2.58 |
| Outstanding Shares | 47,838,738 |
Return
| Return on Equity | -37.36% |
|---|---|
| Return on Assets | -35.01% |
| Return on Invested Capital | -36.83% |
Valuation & Multiples
| P/E Ratio | -12.83 |
|---|---|
| PEG | -22.31 |
| Price to Sales | - |
| Price to Book Ratio | 4.86 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.8 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.03 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data